Abstract:Objectives: α-thalassemia is an autosomal recessive monogenic blood disorder, affecting up to 5% of the world's population. The occurrence rate of the disease in Vietnam varies up to up to 51.5%, with high rate of mutation carriers, of couples consisting of two carriers at risk of bearing a child with fetal Hb Bart, which can develop into hydrops fetalis syndrome, threatening the well-being of the mother and the child. Our study aims to facilitate birth of healthy/asymptomatic children of α-thalassemia carrier couples who received reproductive service at our centre during the period of 2019-2022. Materials and methods: 89 couples at risks of having α-thalassemia offsprings requested IVF procedures and PGD at Post Hospital during 2019-2022 were recruited for investigation. Couple and additional family members' peripheral blood samples of couples and additional family members were subjected to haemoglobin electrophoresis, DNA extraction for α-thalassemia gene mutation detection and STRs linkage analysis. Data were observed and analysed on GeneMarker software. Results: 91 cycles of PGD for α-thalassemia were carried out for 89 couples. α-thalassemia large deletion (--SEA/αα) was the most common mutation identified in 88 couples, in which 4 cases also carried β-thalassemia point mutations. Combining results of PGS and PGD, 278/424 amplified embryos were transferable (HBA-mutation free or carriers of single heterozygous HBA mutation, without chromosomal abnormality). 64/89 couples have been transferred with the embryos (prioritizing mutation free ones over carriers), resulting in the birth of 36 α-thalassemia disease-free children, 17 ongoing pregnancies, and 11 with miscarriages. Conclusion: Successful application of microsatellite-based method in PGD facilitated the birth of 36 healthy children and 17 ongoing pregnancies for 53/64 couples with embryo-transferred. All resulted clinical births displayed confirmation results in line with the PGD results, thus demonstrating the feasibility and credibility of the use of STR markers in PGD.

Diagnosing Β-Thalassemia by Single Cell Duplex-nested PCR

Preimplantation Genetic Diagnosis of Human Embryos with Α-Thalassemia

Embryo genome profiling by single-cell sequencing for preimplantation genetic diagnosis in a β-thalassemia family

Successful Preimplantation Genetic Diagnosis of Α-and Β-Double Thalassemia Combined with HLA Typing by Next Generation Sequencing

A Nested Asymmetric PCR Melting Curve Assay for One-Step Genotyping of Nondeletional α-Thalassemia Mutations

Rapid, Accurate Genotyping of Β‐thalassaemia Mutations Using a Novel Multiplex Primer Extension/denaturing High‐performance Liquid Chromatography Assay

Appropriate whole genome amplification and pathogenic loci detection can improve the accuracy of preimplantation genetic diagnosis for deletional α-thalassemia

Prenatal Diagnosis of Β-Thalassemia Using Multiplex Allele-Specific Amplification (MASPCR) in Chinese Families.

Technically feasible solutions to challenges in preimplantation genetic testing for thalassemia: experiences of multiple centers between 2019 and 2022

Application of short tandem repeats (STRs) in the preimplantation genetic diagnosis (PGD) of α-thalassemia

Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia

Primer-introduced restriction analysis polymerase chain reaction method for non-invasive prenatal testing of β-thalassemia

Accurate detection of α-globin gene copy number variants with two reactions using droplet digital PCR

Prenatal diagnosis of beta-thalassemia by reverse dot-blot hybridization in southern China

Noninvasive prenatal testing of α-thalassemia and β-thalassemia through population-based parental haplotyping

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Karyomapping in Preimplantation Genetic Testing for Β-Thalassemia Combined with HLA Matching: a Systematic Summary.

Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching

Combination of Multiplex Ligation-Dependent Probe Amplification with Gene Sequencing Technology for Detecting Gene Defect of Thalassemia

Single cell genetic diagnosis of spinal muscular atrophy

Analysis of the drawback of the combination of MLPA and gene sequencing technology in detecting thalassemia genes